September 29, 2020

Within3 in The Wall Street Journal

The Wall Street Journal’s coverage of Within3’s $100 million financings round.

Within3 Inc., whose communications platform is used by pharmaceutical and other life sciences companies, has raised $100 million in the first major institutional financing of its 12-year history.

Read the entire article (subscription may be required).

Related Posts:

AI applications

Within3 in European Pharmaceutical Manufacturer: how AI is changing the way pharma companies work

Within3 CTO, AI & Analytics Jason Smith talks to European Pharmaceutical Manufacturer about the possibilities of AI innovation in life science.

Within3 CEO Lance Hill on digital transformation for CROs

Within3 CEO Lance Hill recommends four essential steps for contract research organizations embarking on digital transformation.
insight gap challenges

Within3 in PharmExec: Better Insights Management

A Q&A with Within3 CEO Lance Hill about the insight gap challenge, and how industry leaders are solving it.